CJC-1295 (No DAC) and Ipamorelin are investigational peptides that have been studied for their effects on the growth-hormone signalling pathway.

CJC-1295 (No DAC) is a GHRH analogue, while Ipamorelin is a growth-hormone secretagogue that acts on ghrelin receptors. The combination is researched for its potential effects on natural growth-hormone release.

Research areas include:

* Growth-hormone signalling
* Recovery and tissue research
* Body-composition research
* Metabolic processes
* Exercise and performance-related research